Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

Recently, the European Medicines Agency approved the use of the vasopressin V2 receptor antagonist tolvaptan to slow the progression of cyst development and renal insufficiency of autosomal dominant polycystic kidney disease (ADPKD) in adult patients with chronic kidney disease stages 1–3 at initiat...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Nephrol Dial Transplant
Main Authors: Gansevoort, Ron T., Arici, Mustafa, Benzing, Thomas, Birn, Henrik, Capasso, Giovambattista, Covic, Adrian, Devuyst, Olivier, Drechsler, Christiane, Eckardt, Kai-Uwe, Emma, Francesco, Knebelmann, Bertrand, Le Meur, Yannick, Massy, Ziad A., Ong, Albert C.M., Ortiz, Alberto, Schaefer, Franz, Torra, Roser, Vanholder, Raymond, Więcek, Andrzej, Zoccali, Carmine, Van Biesen, Wim
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2016
Fag:
Cutting-Edge Renal Science
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4762400/
https://ncbi.nlm.nih.gov/pubmed/26908832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv456
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker